To analyze the effect of this compound on the progression of malignant disease, we employed orthotopic and heterotopic syngeneic models of 4T1 breast cancer in mice exhibiting a robust expression of uPA and PAI‐1 in the tumors. This evidence concerns the gene SERPINE1 and breast carcinoma.